Last reviewed · How we verify

NCT06610214: IMPACT-care

IMPACT-care (Improved Medication Communication and Patient Involvement at Care Transitions)

Completed NA Last updated 5 February 2026
What this trial tests

NA trial testing IMPACT-care intervention in Continuity of Patient Care in 231 participants. Completed in 14 January 2026.

Timeline
16 September 2024
Primary endpoint
14 January 2026
14 January 2026

Quick facts

Lead sponsorUppsala University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment231
Start date16 September 2024
Primary completion14 January 2026
Estimated completion14 January 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Uppsala University Hospital

Who can join

65 and older, any sex, with Continuity of Patient Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Transitions of care, especially at hospital discharge, pose significant risks to patient safety. The World Health Organization (WHO) identifies this as a critical area for improvement, particularly for older patients who frequently experience preventable adverse drug events (ADEs) post-discharge.These risks often stem from poor communication between hospitals and subsequent care providers, and inadequate communication with patients and their informal caregivers, leading to gaps in post-discharge care. In Sweden, discharge conversations between hospital physicians and patients are standard practice but often lack structure and patient-centeredness. This can result in patients being poorly prepared for self-care, especially in managing their medications. Aim: To improve the discharge process for older patients, making them (and/or informal caregiver) more informed and involved in their overall care, particularly in medication management. Design: Prospective intervention study with a before-and-after design, supplemented by an Interrupted Time Series (ITS) analysis using an exploratory approach. Setting: Two surgical and one geriatric ward in Region Uppsala. Participants: Patients aged 65 or older, managing medication independently or with assistance from an informal caregiver. Exclusion: Late palliative stage or transition to it during hospital stay; transfer to a non-participating ward; residence outside the hospital's county; admission from or discharge to a nursing home or short-term care facility; inability to receive information and give consent independently (e.g., cognitive impairment, non-contactable); death during hospital stay; inability to communicate in Swedish; previous inclusion in the study; relocation where another department maintains care responsibility; no persistent medication change post-discharge; hospital stay on the study ward of less than 48 weekday hours. Interventions: 1, Information package for patient and/or informal caregiver 2, Preparation of medication-related discharge documentation; 3, Facilitation of discharge communication; 4, Post-discharge follow-up call Primary outcome measure: Quality of medication-related discharge documentation. Data collection and analyses: Data will be collected from patients' electronic health records (EHR), the Swedish National Board of Health and Welfare's Pharmaceutical Register, and research surveys. Analyses will follow the intention-to-treat principle, using descriptive statistics, t-tests for continuous variables, and chi-square tests for categorical variables. Relevance: The study aims to enhance the quality of discharge documentation, improve patients adherence to medication changes, increase their sense of participation and involvement in their overall care, and reduce healthcare consumption.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Improved Medication communication and Patient involvement At Care Transitions (IMPACT-care): study protocol for a pre-post intervention trial in older hospitalised patients.
    Cam H, Franzon K, Östman V, Kälvemark Sporrong S, et al · · 2025 · PMID 40316362 · DOI 10.1136/bmjopen-2025-099547

Verify or expand the search:

Other recruiting trials for Continuity of Patient Care

Currently open trials in the same condition.

Other Uppsala University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06610214.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing